Dear Subscriber, |
Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories. To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y . |
Alcohol / Addiction / Illegal Drugs News | |
Want To Resist Temptation? A New Study Suggests Thinking Might Not Always Help You Uh-oh. Here comes temptation - for a dieter, it's a sweet treat; an alcoholic, a beer; a married man, an attractive, available woman. How to defeat the impulse to gratify desire and stick to your long-term goals of slimness, sobriety, or fidelity?Here's some advice: Don't stop and think. | 28 Oct 2011 |
Allergy News | |
Stop Rising Allergies? Expose Young Babies To Dust Mites In a new radical investigation, doctors at Southampton's teaching hospitals aim to stop the rising allergy epidemic by exposing babies under the age of one to dust mites. According to their theory, exposing them to the prevalent allergen whilst their immune systems are developing should prevent them from becoming allergic in the future. | 28 Oct 2011 |
Alzheimer's / Dementia News | |
Alzheimer's Disease Impact On Caregivers, New Survey According to a new survey, the biggest fear for the majority of family caregivers is their loved one's general health and physical decline followed by the fear that Alzheimer's will rob their loved one of the ability to communicate. | 28 Oct 2011 |
Anxiety / Stress News | |
Friendship Makes A Difference In Stress Regulation Social rejection can cause stress in preschoolers, adolescents, and adults. But what happens in middle childhood, a time when peer rejection can be particularly stressful and friendships are key? A new study has found that friendships serve as a buffer against the negative effects of classmates' rejection. | 28 Oct 2011 |
Arthritis / Rheumatology News | |
Xencor Initiates Phase 1 Study Of XmAb®5871 Therapeutic Antibody For The Treatment Of Autoimmune Diseases Xencor, Inc., a company using its proprietary Protein Design Automation® (PDA) platform technology to engineer next-generation antibodies, announced today the initiation of a Phase 1 clinical trial of XmAb®5871, the company's therapeutic antibody for the treatment of autoimmune diseases. | 28 Oct 2011 |
Study Indicates Nanoparticles Could Help Pain-Relieving Osteoarthritis Drugs Last Longer A novel study demonstrates that using nanoparticles to deliver osteoarthritis drugs to the knee joint could help increase the retention of the drug in the knee cavity, and therefore reduce the frequency of injections patients must receive. | 28 Oct 2011 |
NIH Study Shows Benefits, Limits Of Therapy For Rare Inflammatory Syndrome A study shows that the medication etanercept reduces the frequency and severity of symptoms of TNF receptor-associated periodic syndrome (TRAPS), a rare inherited condition characterized by recurrent fevers, abdominal pain and skin rashes. | 28 Oct 2011 |
Bio-terrorism / Terrorism News | |
Federal Government Wants To Test Anthrax Vaccine On Children Terrorists could use the potentially deadly Anthrax bacteria on an attack against the United States, and there is plenty of vaccine stockpiled for use against this and other possible biological agents of warfare. | 28 Oct 2011 |
Biology / Biochemistry News | |
Improved Characterization Of Nanoparticle Clusters For EHS And Biosensors Research The tendency of nanoparticles to clump together in solution - "agglomeration" - is of great interest because the size of the clusters plays an important role in the behavior of the materials. | 28 Oct 2011 |
Blood / Hematology News | |
Idiopathic Pulmonary Fibrosis Survival Predicted With Blood Proteins According to investigators at the University of Pittsburgh School of Medicine and Centocor R&D, a group of blood proteins can foresee which patients with idiopathic pulmonary fibrosis (IPF) - a progressive lung disease - are more likely to die within two years or live at least five years. | 28 Oct 2011 |
Anti-Coagulant Slows Down Tumor Growth And Spread According to a new study led by Dr Camille Ettelaie of the University of Hull and Dr Anthony Maraveyas, consultant oncologist from Hull's Castle Hill Hospital, anti-coagulants known collectively as Low Molecular Weight Heparin (LMWH), that are given routinely to individuals with cancer in order to treat or lower the risk of thrombosis, might restrain the growth and spread of tumors as well. | 28 Oct 2011 |
Gene Responsible For Relapses In Young Leukemia Patients One of the causes of resistance to cancer treatment in children is now beginning to be elucidated. Acute lymphoblastic leukemia patients with a particular form of the ATF5 gene are at higher risk of having a relapse when treated with E. | 28 Oct 2011 |
High-Dose Melphalan And Autologous Stem Cell Transplantation Increases Survival For AL Amyloidosis Patients A team of researchers led by Boston University School of Medicine (BUSM), has found treatment of selected immunoglobulin light chain (AL) amyloidosis patients with high-dose melphalan and autologous stem cell transplantation (HDM/SCT) resulted in a high organ response rate and increased overall survival (OS), even for those patients who did not achieve a hematologic complete response (CR). | 28 Oct 2011 |
Bones / Orthopedics News | |
Prompt Surgery After Onset Of Lumbar Disc Herniation Symptoms Better For Patients For patients with herniated lumbar disc, symptoms such as pain, function, general health, work status and patient satisfaction, were substantially worse if patients had experienced symptoms for over six months before treatment compared with patients whose symptoms appeared less than half a year before treatment reports a new study in the Journal of Bone and Joint Surgery (JBJS). | 28 Oct 2011 |
Breast Cancer News | |
Preclinical Testing Shows Improved Effectiveness Of New Oncolytic Virus A new fourth-generation oncolytic virus designed to both kill cancer cells and inhibit blood-vessel growth has shown greater effectiveness than earlier versions when tested in animal models of human brain cancer. | 28 Oct 2011 |
Aeterna Zentaris: FDA Grants IND To Investigator At University Of Miami School Of Medicine For Phase 2 Trial With AEZS-108 In Breast Cancer Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") announced that the U.S. Food and Drug Administration (FDA) has granted Alberto J. Montero, M.D., Assistant Professor, Department of Medicine, Division of Hematology/Oncology, Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, an Investigational New Drug (IND) approval for the initiation of a randomized Phase 2 trial in chemotherapy refractory triple-negative (ER/PR/HER2-negative) luteinizing hormone-releasing hormone receptor (LHRH-R)-positive metastatic breast cancer with the Company's targeted cytotoxic LHRH analog, AEZS-108. | 28 Oct 2011 |
Cancer / Oncology News | |
Anti-Coagulant Slows Down Tumor Growth And Spread According to a new study led by Dr Camille Ettelaie of the University of Hull and Dr Anthony Maraveyas, consultant oncologist from Hull's Castle Hill Hospital, anti-coagulants known collectively as Low Molecular Weight Heparin (LMWH), that are given routinely to individuals with cancer in order to treat or lower the risk of thrombosis, might restrain the growth and spread of tumors as well. | 28 Oct 2011 |
Night Shift Working "A Probably Human Carcinogen" In 2007 the International Agency for Research on Cancer (IARC) classified night work as a "probable human carcinogen," since then researchers have been searching for the biological mechanisms involved. | 28 Oct 2011 |
Metastatic Colorectal Cancer - Regorafenib (BAY 73-4506) Improves Overall Survival According to an announcement made by Bayer HealthCare Pharmaceuticals, the Phase III trial of its investigational compound regorafenib (BAY 73-4506) to treat individuals with metastatic colorectal cancer (mCRC) whose disease progressed after approved standard treatments has reached its initial endpoint of statistically significant improvement in overall survival. | 28 Oct 2011 |
Wart Treatment Compound May Treat Leukemia Effectively Researchers have developed a new potential leukemia therapy that specifically targets cancerous cells, without attacking healthy cells. At present the majority of chemotherapy treatments attack both cancer cells and healthy cells, causing considerable adverse effects, such as depression, anxiety, nausea, hair loss and fatigue. | 28 Oct 2011 |
Preclinical Testing Shows Improved Effectiveness Of New Oncolytic Virus A new fourth-generation oncolytic virus designed to both kill cancer cells and inhibit blood-vessel growth has shown greater effectiveness than earlier versions when tested in animal models of human brain cancer. | 28 Oct 2011 |
Long-Term Aspirin Lowers Hereditary Cancer Risk By Over 60% Patients with a family history of cancer who take daily aspirin for a number of years have a 63% lower chance of developing the disease, scientists from the Universities of Newcastle and Leeds, England, reported in the medical journal The Lancet. | 28 Oct 2011 |
Steps Being Taken Towards Achieving An Early Diagnosis Of Cancer Of The Large Intestine Itxaro Perez, a biochemist at the University of the Basque Country (UPV/EHU), has contributed in such a way that, in the long term, the early diagnosis of cancer of the large intestine could be feasible. | 28 Oct 2011 |
New 'Scarless' Surgery Takes Out Tumors Through Natural Skull Opening A technique developed by Johns Hopkins surgeons is providing a new route to get to and remove tumors buried at the base of the skull: through the natural hole behind the molars, above the jawbone and beneath the cheekbone. | 28 Oct 2011 |
Cardiovascular / Cardiology News | |
Black Licorice Halloween Hazard! Don't Eat Too Much Warns FDA Halloween is the biggest candy eating holiday in the US, and many Americans will be stashing up on licorice: but in a timely update to consumers issued this week, the Food and Drug Administration asks: do you realize that you can overdose on licorice? Eating too much (for instance 2 ounces a day for two weeks), especially if you are aged 40 or older, can land you in hospital with irregular heart rhythm (arrhythmia). | 28 Oct 2011 |
Python's Bulging Heart Offers Clues For Human Heart Disease Treatment The Burmese python is a remarkable creature: it doesn't eat for a year with few ill effects, and then swallows prey like deer with a body mass that approaches 100% of its own. When it does this, its heart swells by as much as 40% over the ensuing 72 hours. | 28 Oct 2011 |
ARISTOTLE Trial Finds New Drug May Revolutionize The Treatment Of Atrial Fibrillation New research has the potential to revolutionize the treatment of atrial fibrillation (AF), a condition affecting a quarter of a million Canadians which is expected to strike even more in the coming years, as the Canadian population ages. | 28 Oct 2011 |
Caregivers / Homecare News | |
Alzheimer's Disease Impact On Caregivers, New Survey According to a new survey, the biggest fear for the majority of family caregivers is their loved one's general health and physical decline followed by the fear that Alzheimer's will rob their loved one of the ability to communicate. | 28 Oct 2011 |
Cervical Cancer / HPV Vaccine News | |
HPV For Boys Doesn't Solve Problem, Says Association Of American Physicians And Surgeons The CDC has added still another vaccine to the recommended list: three doses of human papillomavirus (HPV) vaccine (Gardasil) for boys age 11-12. HPV causes genital warts, and four of about 100 strains have been linked to cancer, especially cervical cancer in women. | 28 Oct 2011 |
Clinical Trials / Drug Trials News | |
Aeterna Zentaris: FDA Grants IND To Investigator At University Of Miami School Of Medicine For Phase 2 Trial With AEZS-108 In Breast Cancer Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") announced that the U.S. Food and Drug Administration (FDA) has granted Alberto J. Montero, M.D., Assistant Professor, Department of Medicine, Division of Hematology/Oncology, Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, an Investigational New Drug (IND) approval for the initiation of a randomized Phase 2 trial in chemotherapy refractory triple-negative (ER/PR/HER2-negative) luteinizing hormone-releasing hormone receptor (LHRH-R)-positive metastatic breast cancer with the Company's targeted cytotoxic LHRH analog, AEZS-108. | 28 Oct 2011 |
Xencor Initiates Phase 1 Study Of XmAb®5871 Therapeutic Antibody For The Treatment Of Autoimmune Diseases Xencor, Inc., a company using its proprietary Protein Design Automation® (PDA) platform technology to engineer next-generation antibodies, announced today the initiation of a Phase 1 clinical trial of XmAb®5871, the company's therapeutic antibody for the treatment of autoimmune diseases. | 28 Oct 2011 |
Colorectal Cancer News | |
Metastatic Colorectal Cancer - Regorafenib (BAY 73-4506) Improves Overall Survival According to an announcement made by Bayer HealthCare Pharmaceuticals, the Phase III trial of its investigational compound regorafenib (BAY 73-4506) to treat individuals with metastatic colorectal cancer (mCRC) whose disease progressed after approved standard treatments has reached its initial endpoint of statistically significant improvement in overall survival. | 28 Oct 2011 |
Conferences News | |
Global Benchmarking In The Pharma SFE It is no secret that the Pharma sector is becoming progressively more competitive. As well as this, the current economic situation is making it harder for Pharma companies to sell their products. | 28 Oct 2011 |
Pharma Industry Unites With Academia To Tackle Ongoing Problem Selecting and screening the correct polymorphs and ensuring the characterisation of the co-crystals in the most efficient and effective way has never been more vital. According to George Tranter from Chiralabs, "Crystallisation is one of the biggest problems of the pharmaceutical industry". | 28 Oct 2011 |
British Appetite For Zombies Is Becoming A Growing Trend Due To A Feeling Of Powerlessness Shared By Many The British appetite for zombies is becoming a growing trend. From computer games and films to organised zombie walks though Britain's cities, the proliferation of zombies seems to be everywhere. | 28 Oct 2011 |
Cosmetic Medicine / Plastic Surgery News | |
Fast High Precision Eye-Surgery Robot Developed At Eindhoven University Researcher Thijs Meenink at Eindhoven University of Technology (TU/e) has developed a smart eye-surgery robot that allows eye surgeons to operate with increased ease and greater precision on the retina and the vitreous humor of the eye. | 28 Oct 2011 |
Dentistry News | |
Premature Children Have Smaller Teeth The size of teeth in premature children is smaller. This has been established in a study from the Faculty of Odontology at Malmö University in Sweden.Our knowledge about premature children, and their physical and mental development as they grow up, is constantly growing. | 28 Oct 2011 |
Dermatology News | |
Lab-Made Skin Cells Will Aid Transplantation, Cancer, Drug Discovery Research, Say Penn Scientists The pigmented cells called melanocytes aren't just for making freckles and tans. Melanocytes absorb ultraviolet light, protecting the skin from the harmful effects of the sun. They also are the cells that go haywire in melanoma, as well as in more common conditions as vitiligo and albinism. | 28 Oct 2011 |
Eating Disorders News | |
Study Shows Why Underrepresented Men Should Be Included In Binge Eating Research Binge eating is a disorder which affects both men and women, yet men remain underrepresented in research. A new study published in the International Journal of Eating Disorders has found that the medical impact of the disorder is just as damaging to men as it is to women, yet research has shown that the number of men seeking treatment is far lower than the estimated number of sufferers. | 28 Oct 2011 |
Eye Health / Blindness News | |
Fast High Precision Eye-Surgery Robot Developed At Eindhoven University Researcher Thijs Meenink at Eindhoven University of Technology (TU/e) has developed a smart eye-surgery robot that allows eye surgeons to operate with increased ease and greater precision on the retina and the vitreous humor of the eye. | 28 Oct 2011 |
GastroIntestinal / Gastroenterology News | |
Friendly Gut Bacteria May Trigger MS In an astonishing new study published in Nature today, researchers at the Max Planck Institute of Neurobiology in Martinsried in Munich, Germany say they have found evidence that suggests multiple sclerosis (MS) is triggered by natural intestinal flora, the so-called friendly bacteria that reside in the gut. | 28 Oct 2011 |
Metastatic Colorectal Cancer - Regorafenib (BAY 73-4506) Improves Overall Survival According to an announcement made by Bayer HealthCare Pharmaceuticals, the Phase III trial of its investigational compound regorafenib (BAY 73-4506) to treat individuals with metastatic colorectal cancer (mCRC) whose disease progressed after approved standard treatments has reached its initial endpoint of statistically significant improvement in overall survival. | 28 Oct 2011 |
Natural Intestinal Flora Involved In The Emergence Of Multiple Sclerosis Multiple sclerosis is caused by a combination of genetic and environmental factors. For a long time, pathogens were believed to be such external influences. According to scientists from the Max Planck Institute of Neurobiology in Martinsried, however, it is apparently not harmful bacteria that trigger multiple sclerosis, but beneficial ones specifically, the natural intestinal flora, which every human being needs for digestion. | 28 Oct 2011 |
New Drug Targets Revealed From Giant Parasitic Worm Genome Sequence Scientists have identified the genetic blueprint of the giant intestinal roundworm, Ascaris suum, revealing potential targets to control the devastating parasitic disease, ascariasis which affects more than one billion people in China, South East Asia, South America and parts of Africa, killing thousands of people annually and causing chronic effects in young children. | 28 Oct 2011 |
Steps Being Taken Towards Achieving An Early Diagnosis Of Cancer Of The Large Intestine Itxaro Perez, a biochemist at the University of the Basque Country (UPV/EHU), has contributed in such a way that, in the long term, the early diagnosis of cancer of the large intestine could be feasible. | 28 Oct 2011 |
Genetics News | |
Better Understanding Of Parasite That Causes Leishmaniasis A significant step towards understanding the genetic make-up of a parasite which causes leishmaniasis - a flesh-eating disease spread by the bite of a female sand fly - has been made by a team of researchers from the University of Glasgow. | 28 Oct 2011 |
Abbott's Genetic Test For Acute Myeloid Leukemia Prognosis Cleared By FDA Abbott (NYSE: ABT) announced it has received 510(k) clearance from the U.S. Food and Drug Administration for a new in vitro diagnostic test to aid in determining the prognosis of patients with acute myeloid leukemia (AML), one of the most common types of leukemia in older adults. | 28 Oct 2011 |
Our Brains Are Made Of The Same Stuff, Despite DNA Differences Despite vast differences in the genetic code across individuals and ethnicities, the human brain shows a "consistent molecular architecture," say researchers supported by the National Institutes of Health. | 28 Oct 2011 |
Found In The Developing Brain: Mental Health Risk Genes And Gender Differences Most genes associated with psychiatric illnesses are expressed before birth in the developing human brain, a massive study headed by Yale University researchers discovered. In addition, hundreds of genetic differences were found between males and females as their brains take shape in the womb, the study in the Oct. | 28 Oct 2011 |
New Drug Targets Revealed From Giant Parasitic Worm Genome Sequence Scientists have identified the genetic blueprint of the giant intestinal roundworm, Ascaris suum, revealing potential targets to control the devastating parasitic disease, ascariasis which affects more than one billion people in China, South East Asia, South America and parts of Africa, killing thousands of people annually and causing chronic effects in young children. | 28 Oct 2011 |
Gene Responsible For Relapses In Young Leukemia Patients One of the causes of resistance to cancer treatment in children is now beginning to be elucidated. Acute lymphoblastic leukemia patients with a particular form of the ATF5 gene are at higher risk of having a relapse when treated with E. | 28 Oct 2011 |
Study Identifies Genetic Basis Of Human Metabolic Individuality In what is so far the largest investigation of its kind, researchers uncovered a wide range of new insights about common diseases and how they are affected by differences between two persons' genes. | 28 Oct 2011 |
Heart Disease News | |
Python's Bulging Heart Offers Clues For Human Heart Disease Treatment The Burmese python is a remarkable creature: it doesn't eat for a year with few ill effects, and then swallows prey like deer with a body mass that approaches 100% of its own. When it does this, its heart swells by as much as 40% over the ensuing 72 hours. | 28 Oct 2011 |
Immune System / Vaccines News | |
Federal Government Wants To Test Anthrax Vaccine On Children Terrorists could use the potentially deadly Anthrax bacteria on an attack against the United States, and there is plenty of vaccine stockpiled for use against this and other possible biological agents of warfare. | 28 Oct 2011 |
Friendly Gut Bacteria May Trigger MS In an astonishing new study published in Nature today, researchers at the Max Planck Institute of Neurobiology in Martinsried in Munich, Germany say they have found evidence that suggests multiple sclerosis (MS) is triggered by natural intestinal flora, the so-called friendly bacteria that reside in the gut. | 28 Oct 2011 |
Xencor Initiates Phase 1 Study Of XmAb®5871 Therapeutic Antibody For The Treatment Of Autoimmune Diseases Xencor, Inc., a company using its proprietary Protein Design Automation® (PDA) platform technology to engineer next-generation antibodies, announced today the initiation of a Phase 1 clinical trial of XmAb®5871, the company's therapeutic antibody for the treatment of autoimmune diseases. | 28 Oct 2011 |
What Role Do Cytokines Play In Autoimmune Diseases? Cytokines, a varied group of signaling chemicals in the body, have been described as the software that runs the immune system, but when that software malfunctions, dysregulation of the immune system can result in debilitating autoimmune diseases such as lupus, arthritis, and diabetes. | 28 Oct 2011 |
NIH Study Shows Benefits, Limits Of Therapy For Rare Inflammatory Syndrome A study shows that the medication etanercept reduces the frequency and severity of symptoms of TNF receptor-associated periodic syndrome (TRAPS), a rare inherited condition characterized by recurrent fevers, abdominal pain and skin rashes. | 28 Oct 2011 |
Infection Is An Important Post-Stroke Problem After a stroke the brain tries to protect itself by blocking all inflammation. However, this also makes the patient highly susceptible to infection which can lead to death. Researchers have now discovered the mechanism behind this response and how to possibly treat it. | 28 Oct 2011 |
Multiple Malaria Vaccine Offers Protection To People Most At Risk A new malaria vaccine could be the first to tackle different forms of the disease and help those most vulnerable to infection, a study suggests.The new vaccine is designed to trigger production of a range of antibodies to fight the many different types of parasite causing the disease. | 28 Oct 2011 |
Researchers Develop Method To Better Estimate Vaccine Coverage Immunizations are a valuable tool for controlling infectious diseases among populations both in the U.S. and globally. Routine immunizations and supplemental immunization activities, such as immunization campaigns, are designed to provide immunization coverage to entire populations. | 28 Oct 2011 |
Source Found For Immune System Effects On Learning, Memory Immune system cells of the brain, which scavenge pathogens and damaged neurons, are also key players in memory and learning, according to new research by Duke neuroscientists.Earlier studies by Staci Bilbo, an assistant professor in psychology & neuroscience, had shown that laboratory rats experiencing an infection at an early age have an aggressive immune response to subsequent infections, which also harms their learning and memory. | 28 Oct 2011 |
Infectious Diseases / Bacteria / Viruses News | |
Better Understanding Of Parasite That Causes Leishmaniasis A significant step towards understanding the genetic make-up of a parasite which causes leishmaniasis - a flesh-eating disease spread by the bite of a female sand fly - has been made by a team of researchers from the University of Glasgow. | 28 Oct 2011 |
Thomas Jefferson University Hospital Cuts Whipple Procedure Wound Infections In Half With New Measures Thomas Jefferson University Hospital surgeons found that a carefully-selected surgical care check list of 12 measures reduced Whipple procedure wound infections by nearly 50 percent.Smoking cessation at least two weeks prior to surgery, gown and glove change prior to skin closure, and using clippers over razors to shave the surgical area are some of the measures that helped reduced infection rates, according to the study published in the October 26 online issue of the Journal of Surgical Research. | 28 Oct 2011 |
Litigation / Medical Malpractice News | |
Guilty Plea In Organ Theft Case A Legal First In what is believed to be the first legally proved case of organ trafficking, Levy Izhak Rosenbaum, 60 admitted to helping secure organs for US customers and pleaded guilt to the charges against him. | 28 Oct 2011 |
Lupus News | |
Statins Disappoint In Atherosclerosis Progression In Children With Lupus According to the American College of Rheumatology (ACR) 322,000 adult Americans are affected by systemic lupus erythematosus (SLE) with approximately 5,000 to 10,000 children in the U.S. affected by lupus (Lehman 1996), although exact figures for pediatric SLE cases remain difficult to establish. | 28 Oct 2011 |
Lymphoma / Leukemia / Myeloma News | |
Wart Treatment Compound May Treat Leukemia Effectively Researchers have developed a new potential leukemia therapy that specifically targets cancerous cells, without attacking healthy cells. At present the majority of chemotherapy treatments attack both cancer cells and healthy cells, causing considerable adverse effects, such as depression, anxiety, nausea, hair loss and fatigue. | 28 Oct 2011 |
Abbott's Genetic Test For Acute Myeloid Leukemia Prognosis Cleared By FDA Abbott (NYSE: ABT) announced it has received 510(k) clearance from the U.S. Food and Drug Administration for a new in vitro diagnostic test to aid in determining the prognosis of patients with acute myeloid leukemia (AML), one of the most common types of leukemia in older adults. | 28 Oct 2011 |
Compound Found In Common Wart Treatment Shows Promise As Leukemia Therapy A new potential leukemia therapy targets only cancer cells, while leaving healthy cells alone. Many current chemotherapy treatments affect cancer cells and healthy cells, causing significant side effects, such as fatigue, hair loss, nausea, anxiety and depression. | 28 Oct 2011 |
Gene Responsible For Relapses In Young Leukemia Patients One of the causes of resistance to cancer treatment in children is now beginning to be elucidated. Acute lymphoblastic leukemia patients with a particular form of the ATF5 gene are at higher risk of having a relapse when treated with E. | 28 Oct 2011 |
Bedside Assessment May Provide Better Outcomes For Older Cancer Patients In geriatric medicine, the adage that age is just a number holds true. New research from Wake Forest Baptist Medical Center uses a simple assessment tool to determine how well older adults diagnosed with acute myelogenous leukemia (AML) can handle treatment. | 28 Oct 2011 |
Medical Devices / Diagnostics News | |
Abbott's Genetic Test For Acute Myeloid Leukemia Prognosis Cleared By FDA Abbott (NYSE: ABT) announced it has received 510(k) clearance from the U.S. Food and Drug Administration for a new in vitro diagnostic test to aid in determining the prognosis of patients with acute myeloid leukemia (AML), one of the most common types of leukemia in older adults. | 28 Oct 2011 |
Solta Medical Reports FDA Clearance Received For Second Generation LipoSonix® System Solta Medical, Inc. (Solta) (Nasdaq: SLTM), a global leader in the medical aesthetics market, today announced that Medicis Technologies Corporation (formerly LipoSonix, Inc.), a subsidiary of Medicis Pharmaceutical Corporation (Medicis) has received U. | 28 Oct 2011 |
Accuray Receives 510(k) Clearance For A Rotational Dose Control For The TomoTherapy System Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced that the U.S. Food and Drug Administration (FDA) has granted the company 510(k) clearance to market the Dose Control System (DCS), a new feature for Accuray's TomoTherapy® System that improves system performance. | 28 Oct 2011 |
Fast High Precision Eye-Surgery Robot Developed At Eindhoven University Researcher Thijs Meenink at Eindhoven University of Technology (TU/e) has developed a smart eye-surgery robot that allows eye surgeons to operate with increased ease and greater precision on the retina and the vitreous humor of the eye. | 28 Oct 2011 |
Advance Toward A Breath Test To Diagnose Multiple Sclerosis Scientists are reporting the development and successful tests in humans of a sensor array that can diagnose multiple sclerosis (MS) from exhaled breath, an advance that they describe as a landmark in the long search for a fast, inexpensive and non-invasive test for MS -- the most common neurological disease in young adults. | 28 Oct 2011 |
Improved Characterization Of Nanoparticle Clusters For EHS And Biosensors Research The tendency of nanoparticles to clump together in solution - "agglomeration" - is of great interest because the size of the clusters plays an important role in the behavior of the materials. | 28 Oct 2011 |
Medicare / Medicaid / SCHIP News | |
Policymakers Should Prepare For Major Uncertainties With Medicaid Expansion The number of low-income, uninsured Americans enrolling in Medicaid under the expanded coverage made possible by the Affordable Care Act (ACA) of 2010 could vary considerably from the levels currently projected by the Congressional Budget Office (CBO) and the Centers for Medicare and Medicaid Services (CMS), according to a new study by Harvard School of Public Health (HSPH) researchers. | 28 Oct 2011 |
Multiple Sclerosis News | |
Friendly Gut Bacteria May Trigger MS In an astonishing new study published in Nature today, researchers at the Max Planck Institute of Neurobiology in Martinsried in Munich, Germany say they have found evidence that suggests multiple sclerosis (MS) is triggered by natural intestinal flora, the so-called friendly bacteria that reside in the gut. | 28 Oct 2011 |
Natural Intestinal Flora Involved In The Emergence Of Multiple Sclerosis Multiple sclerosis is caused by a combination of genetic and environmental factors. For a long time, pathogens were believed to be such external influences. According to scientists from the Max Planck Institute of Neurobiology in Martinsried, however, it is apparently not harmful bacteria that trigger multiple sclerosis, but beneficial ones specifically, the natural intestinal flora, which every human being needs for digestion. | 28 Oct 2011 |
Advance Toward A Breath Test To Diagnose Multiple Sclerosis Scientists are reporting the development and successful tests in humans of a sensor array that can diagnose multiple sclerosis (MS) from exhaled breath, an advance that they describe as a landmark in the long search for a fast, inexpensive and non-invasive test for MS -- the most common neurological disease in young adults. | 28 Oct 2011 |
Medical Researchers ID Potential New Drug Target That Could Stop Debilitating Effects Of MS Medical researchers at the University of Alberta have discovered a potential new drug target for Multiple Sclerosis that could prevent physical disability associated with the disease, once a new drug is developed. | 28 Oct 2011 |
Neurology / Neuroscience News | |
Meninges Is Source Of Self-Renewing Stem Cells, Potential For Spinal Cord Injury Treatment In a study published in STEM CELLS, Italian and Spanish scientists have provided the first evidence to show that meninges, the membrane which envelops the central nervous system, is a potential source of self-renewing stem cells. | 28 Oct 2011 |
Preclinical Testing Shows Improved Effectiveness Of New Oncolytic Virus A new fourth-generation oncolytic virus designed to both kill cancer cells and inhibit blood-vessel growth has shown greater effectiveness than earlier versions when tested in animal models of human brain cancer. | 28 Oct 2011 |
Our Brains Are Made Of The Same Stuff, Despite DNA Differences Despite vast differences in the genetic code across individuals and ethnicities, the human brain shows a "consistent molecular architecture," say researchers supported by the National Institutes of Health. | 28 Oct 2011 |
Found In The Developing Brain: Mental Health Risk Genes And Gender Differences Most genes associated with psychiatric illnesses are expressed before birth in the developing human brain, a massive study headed by Yale University researchers discovered. In addition, hundreds of genetic differences were found between males and females as their brains take shape in the womb, the study in the Oct. | 28 Oct 2011 |
New 'Scarless' Surgery Takes Out Tumors Through Natural Skull Opening A technique developed by Johns Hopkins surgeons is providing a new route to get to and remove tumors buried at the base of the skull: through the natural hole behind the molars, above the jawbone and beneath the cheekbone. | 28 Oct 2011 |
Source Found For Immune System Effects On Learning, Memory Immune system cells of the brain, which scavenge pathogens and damaged neurons, are also key players in memory and learning, according to new research by Duke neuroscientists.Earlier studies by Staci Bilbo, an assistant professor in psychology & neuroscience, had shown that laboratory rats experiencing an infection at an early age have an aggressive immune response to subsequent infections, which also harms their learning and memory. | 28 Oct 2011 |
Nursing / Midwifery News | |
New Study Finds Fetal Heart Rate Not A Good Indicator Of A Baby's Health Physicians preparing to deliver a baby look at fetal heart rate patterns to guide them in deciding whether or not to perform a C- section. But a new study by maternal-fetal medicine specialists at Intermountain Medical Center shows that those heart rate patterns may not be a good indicator of a baby's health, and in fact may lead to unnecessary interventions and higher costs. | 28 Oct 2011 |
Nutrition / Diet News | |
Black Licorice Halloween Hazard! Don't Eat Too Much Warns FDA Halloween is the biggest candy eating holiday in the US, and many Americans will be stashing up on licorice: but in a timely update to consumers issued this week, the Food and Drug Administration asks: do you realize that you can overdose on licorice? Eating too much (for instance 2 ounces a day for two weeks), especially if you are aged 40 or older, can land you in hospital with irregular heart rhythm (arrhythmia). | 28 Oct 2011 |
How Do Europeans React At Being Told What To Eat? As part of the larger EATWELL Project, which is focused on effective policy interventions to promote healthy nutrition for all in the EU, the EATWELL survey is an international study based on random samples of more than 3,000 computer-aided web interviews that assessed public acceptance of nutrition policies in the UK, Italy, Belgium, Denmark and Poland depending on age, economic wealth, political views, obesity attributions, and the willingness to pay for such policies. | 28 Oct 2011 |
Do EU-Funded Diet Projects Work? An EU (FP7) funded project called EATWELL (Interventions to Promote Healthy Eating Habits: Evaluation and Recommendations) aims to overcome unhealthy diets, one of the biggest public health challenges of the 21st century. | 28 Oct 2011 |
Low-Fat Diet With Fish Oil Supplements Slows Growth Rate Of Prostate Cancer Cells Researchers at UCLA's Jonsson Comprehensive Cancer Center have discovered that the growth of prostate cancer cells slowed down in men that ate a low-fat diet together with fish oil supplements for four to six weeks before prostate removal compared to men who ate a Western diet high in fat. | 28 Oct 2011 |
Food Chemical Regulations Rely Heavily On Industry Self-Policing And Lack Transparency Safety decisions concerning one-third of the more than 10,000 substances that may be added to human food were made by food manufacturers and a trade association without review by the U.S. Food and Drug Administration (FDA), according to an analysis spearheaded by the Pew Health Group. | 28 Oct 2011 |
'Magnetic Tongue' Ready To Help Produce Tastier Processed Foods The "electronic nose," which detects odors, has a companion among emerging futuristic "e-sensing" devices intended to replace abilities that once were strictly human-and-animal-only. It is a "magnetic tongue" -- a method used to "taste" food and identify ingredients that people describe as sweet, bitter, sour, etc. | 28 Oct 2011 |
Pain / Anesthetics News | |
Study Indicates Nanoparticles Could Help Pain-Relieving Osteoarthritis Drugs Last Longer A novel study demonstrates that using nanoparticles to deliver osteoarthritis drugs to the knee joint could help increase the retention of the drug in the knee cavity, and therefore reduce the frequency of injections patients must receive. | 28 Oct 2011 |
Pediatrics / Children's Health News | |
Federal Government Wants To Test Anthrax Vaccine On Children Terrorists could use the potentially deadly Anthrax bacteria on an attack against the United States, and there is plenty of vaccine stockpiled for use against this and other possible biological agents of warfare. | 28 Oct 2011 |
Stop Rising Allergies? Expose Young Babies To Dust Mites In a new radical investigation, doctors at Southampton's teaching hospitals aim to stop the rising allergy epidemic by exposing babies under the age of one to dust mites. According to their theory, exposing them to the prevalent allergen whilst their immune systems are developing should prevent them from becoming allergic in the future. | 28 Oct 2011 |
Statins Disappoint In Atherosclerosis Progression In Children With Lupus According to the American College of Rheumatology (ACR) 322,000 adult Americans are affected by systemic lupus erythematosus (SLE) with approximately 5,000 to 10,000 children in the U.S. affected by lupus (Lehman 1996), although exact figures for pediatric SLE cases remain difficult to establish. | 28 Oct 2011 |
Premature Children Have Smaller Teeth The size of teeth in premature children is smaller. This has been established in a study from the Faculty of Odontology at Malmö University in Sweden.Our knowledge about premature children, and their physical and mental development as they grow up, is constantly growing. | 28 Oct 2011 |
Hard Times During Adolescence Point To Health Problems Later In Life Study demonstrates that social stressors around the transition into adulthood sow the seeds of disease in mid-adulthood.Being hard up socially and financially during adolescence and early adulthood takes its toll on the body, and leads to physiological wear and tear in middle aged men and women, irrespective of how tough things have been in the interim. | 28 Oct 2011 |
Study Uncovers Clues To Young Children's Aggressive Behavior Children who are persistently aggressive, defiant, and explosive by the time they're in kindergarten very often have tumultuous relationships with their parents from early on. A new longitudinal study suggests that a cycle involving parenting styles and hostility between mothers and toddlers is at play. | 28 Oct 2011 |
Friendship Makes A Difference In Stress Regulation Social rejection can cause stress in preschoolers, adolescents, and adults. But what happens in middle childhood, a time when peer rejection can be particularly stressful and friendships are key? A new study has found that friendships serve as a buffer against the negative effects of classmates' rejection. | 28 Oct 2011 |
Preschoolers' Language Skills Improve More When They're Placed With More-Skilled Peers Preschool children with relatively poor language skills improve more if they are placed in classrooms with high-achieving students, a new study found.Researchers found that children with relatively poor language skills either didn't improve over the course of one academic year, or actually lost ground in development of language skills, when they were placed with other low-achieving students. | 28 Oct 2011 |
Pharma Industry / Biotech Industry News | |
Global Benchmarking In The Pharma SFE It is no secret that the Pharma sector is becoming progressively more competitive. As well as this, the current economic situation is making it harder for Pharma companies to sell their products. | 28 Oct 2011 |
Pharma Industry Unites With Academia To Tackle Ongoing Problem Selecting and screening the correct polymorphs and ensuring the characterisation of the co-crystals in the most efficient and effective way has never been more vital. According to George Tranter from Chiralabs, "Crystallisation is one of the biggest problems of the pharmaceutical industry". | 28 Oct 2011 |
Chiral Metal Surfaces May Help To Manufacture Pharmaceuticals New research shows how metal surfaces that lack mirror symmetry could provide a novel approach towards manufacturing pharmaceuticals.These 'intrinsically chiral' metal surfaces offer potential new ways to control chiral chemistry, pointing to the intriguing possibility of using heterogeneous catalysis in drug synthesis. | 28 Oct 2011 |
Pregnancy / Obstetrics News | |
New Study Finds Fetal Heart Rate Not A Good Indicator Of A Baby's Health Physicians preparing to deliver a baby look at fetal heart rate patterns to guide them in deciding whether or not to perform a C- section. But a new study by maternal-fetal medicine specialists at Intermountain Medical Center shows that those heart rate patterns may not be a good indicator of a baby's health, and in fact may lead to unnecessary interventions and higher costs. | 28 Oct 2011 |
Prostate / Prostate Cancer News | |
Low-Fat Diet With Fish Oil Supplements Slows Growth Rate Of Prostate Cancer Cells Researchers at UCLA's Jonsson Comprehensive Cancer Center have discovered that the growth of prostate cancer cells slowed down in men that ate a low-fat diet together with fish oil supplements for four to six weeks before prostate removal compared to men who ate a Western diet high in fat. | 28 Oct 2011 |
Psychology / Psychiatry News | |
Study Uncovers Clues To Young Children's Aggressive Behavior Children who are persistently aggressive, defiant, and explosive by the time they're in kindergarten very often have tumultuous relationships with their parents from early on. A new longitudinal study suggests that a cycle involving parenting styles and hostility between mothers and toddlers is at play. | 28 Oct 2011 |
British Appetite For Zombies Is Becoming A Growing Trend Due To A Feeling Of Powerlessness Shared By Many The British appetite for zombies is becoming a growing trend. From computer games and films to organised zombie walks though Britain's cities, the proliferation of zombies seems to be everywhere. | 28 Oct 2011 |
Religious, Spiritual Support Benefits Men And Women Facing Chronic Illness, MU Study Finds Individuals who practice religion and spirituality report better physical and mental health than those who do not. To better understand this relationship and how spirituality/religion can be used for coping with significant health issues, University of Missouri researchers are examining what aspects of religion are most beneficial and for what populations. | 28 Oct 2011 |
Want To Resist Temptation? A New Study Suggests Thinking Might Not Always Help You Uh-oh. Here comes temptation - for a dieter, it's a sweet treat; an alcoholic, a beer; a married man, an attractive, available woman. How to defeat the impulse to gratify desire and stick to your long-term goals of slimness, sobriety, or fidelity?Here's some advice: Don't stop and think. | 28 Oct 2011 |
Public Health News | |
Financial Rewards In Health Management Programs Rose Considerably, USA As employers in the U.S. seek strategies for addressing increasing health-related costs, a survey conducted by Towers Watson (NYSE, NASDAQ:TW), a global and professional services company and the National Business Group of Health, comprising of 335 medium to large companies* reported that they remain strongly committed to productivity and health improving programs. | 28 Oct 2011 |
Hard Times During Adolescence Point To Health Problems Later In Life Study demonstrates that social stressors around the transition into adulthood sow the seeds of disease in mid-adulthood.Being hard up socially and financially during adolescence and early adulthood takes its toll on the body, and leads to physiological wear and tear in middle aged men and women, irrespective of how tough things have been in the interim. | 28 Oct 2011 |
Recycling Thermal Cash Register Receipts Contaminates Paper Products With BPA Bisphenol A (BPA) -- a substance that may have harmful health effects -- occurs in 94 percent of thermal cash register receipts, scientists are reporting. The recycling of those receipts, they add, is a source of BPA contamination of paper napkins, toilet paper, food packaging and other paper products. | 28 Oct 2011 |
Religious, Spiritual Support Benefits Men And Women Facing Chronic Illness, MU Study Finds Individuals who practice religion and spirituality report better physical and mental health than those who do not. To better understand this relationship and how spirituality/religion can be used for coping with significant health issues, University of Missouri researchers are examining what aspects of religion are most beneficial and for what populations. | 28 Oct 2011 |
Radiology / Nuclear Medicine News | |
Accuray Receives 510(k) Clearance For A Rotational Dose Control For The TomoTherapy System Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced that the U.S. Food and Drug Administration (FDA) has granted the company 510(k) clearance to market the Dose Control System (DCS), a new feature for Accuray's TomoTherapy® System that improves system performance. | 28 Oct 2011 |
Regulatory Affairs / Drug Approvals News | |
Black Licorice Halloween Hazard! Don't Eat Too Much Warns FDA Halloween is the biggest candy eating holiday in the US, and many Americans will be stashing up on licorice: but in a timely update to consumers issued this week, the Food and Drug Administration asks: do you realize that you can overdose on licorice? Eating too much (for instance 2 ounces a day for two weeks), especially if you are aged 40 or older, can land you in hospital with irregular heart rhythm (arrhythmia). | 28 Oct 2011 |
Solta Medical Reports FDA Clearance Received For Second Generation LipoSonix® System Solta Medical, Inc. (Solta) (Nasdaq: SLTM), a global leader in the medical aesthetics market, today announced that Medicis Technologies Corporation (formerly LipoSonix, Inc.), a subsidiary of Medicis Pharmaceutical Corporation (Medicis) has received U. | 28 Oct 2011 |
Aeterna Zentaris: FDA Grants IND To Investigator At University Of Miami School Of Medicine For Phase 2 Trial With AEZS-108 In Breast Cancer Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") announced that the U.S. Food and Drug Administration (FDA) has granted Alberto J. Montero, M.D., Assistant Professor, Department of Medicine, Division of Hematology/Oncology, Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, an Investigational New Drug (IND) approval for the initiation of a randomized Phase 2 trial in chemotherapy refractory triple-negative (ER/PR/HER2-negative) luteinizing hormone-releasing hormone receptor (LHRH-R)-positive metastatic breast cancer with the Company's targeted cytotoxic LHRH analog, AEZS-108. | 28 Oct 2011 |
Accuray Receives 510(k) Clearance For A Rotational Dose Control For The TomoTherapy System Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced that the U.S. Food and Drug Administration (FDA) has granted the company 510(k) clearance to market the Dose Control System (DCS), a new feature for Accuray's TomoTherapy® System that improves system performance. | 28 Oct 2011 |
Rehabilitation / Physical Therapy News | |
Meninges Is Source Of Self-Renewing Stem Cells, Potential For Spinal Cord Injury Treatment In a study published in STEM CELLS, Italian and Spanish scientists have provided the first evidence to show that meninges, the membrane which envelops the central nervous system, is a potential source of self-renewing stem cells. | 28 Oct 2011 |
Respiratory / Asthma News | |
Idiopathic Pulmonary Fibrosis Survival Predicted With Blood Proteins According to investigators at the University of Pittsburgh School of Medicine and Centocor R&D, a group of blood proteins can foresee which patients with idiopathic pulmonary fibrosis (IPF) - a progressive lung disease - are more likely to die within two years or live at least five years. | 28 Oct 2011 |
Researchers Identify Potential Risk Factors For Severe Altitude Sickness According to a study published online ahead of the print edition of the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine, physicians can determine who is likely to have a higher risk of severe high altitude illness (SHAI) by measuring specific, exercise-related responses. | 28 Oct 2011 |
Seniors / Aging News | |
Bedside Assessment May Provide Better Outcomes For Older Cancer Patients In geriatric medicine, the adage that age is just a number holds true. New research from Wake Forest Baptist Medical Center uses a simple assessment tool to determine how well older adults diagnosed with acute myelogenous leukemia (AML) can handle treatment. | 28 Oct 2011 |
Sleep / Sleep Disorders / Insomnia News | |
Night Shift Working "A Probably Human Carcinogen" In 2007 the International Agency for Research on Cancer (IARC) classified night work as a "probable human carcinogen," since then researchers have been searching for the biological mechanisms involved. | 28 Oct 2011 |
Smoking / Quit Smoking News | |
Want To Resist Temptation? A New Study Suggests Thinking Might Not Always Help You Uh-oh. Here comes temptation - for a dieter, it's a sweet treat; an alcoholic, a beer; a married man, an attractive, available woman. How to defeat the impulse to gratify desire and stick to your long-term goals of slimness, sobriety, or fidelity?Here's some advice: Don't stop and think. | 28 Oct 2011 |
Sports Medicine / Fitness News | |
Researchers Identify Potential Risk Factors For Severe Altitude Sickness According to a study published online ahead of the print edition of the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine, physicians can determine who is likely to have a higher risk of severe high altitude illness (SHAI) by measuring specific, exercise-related responses. | 28 Oct 2011 |
Statins News | |
Statins Disappoint In Atherosclerosis Progression In Children With Lupus According to the American College of Rheumatology (ACR) 322,000 adult Americans are affected by systemic lupus erythematosus (SLE) with approximately 5,000 to 10,000 children in the U.S. affected by lupus (Lehman 1996), although exact figures for pediatric SLE cases remain difficult to establish. | 28 Oct 2011 |
Stem Cell Research News | |
Meninges Is Source Of Self-Renewing Stem Cells, Potential For Spinal Cord Injury Treatment In a study published in STEM CELLS, Italian and Spanish scientists have provided the first evidence to show that meninges, the membrane which envelops the central nervous system, is a potential source of self-renewing stem cells. | 28 Oct 2011 |
Lab-Made Skin Cells Will Aid Transplantation, Cancer, Drug Discovery Research, Say Penn Scientists The pigmented cells called melanocytes aren't just for making freckles and tans. Melanocytes absorb ultraviolet light, protecting the skin from the harmful effects of the sun. They also are the cells that go haywire in melanoma, as well as in more common conditions as vitiligo and albinism. | 28 Oct 2011 |
High-Dose Melphalan And Autologous Stem Cell Transplantation Increases Survival For AL Amyloidosis Patients A team of researchers led by Boston University School of Medicine (BUSM), has found treatment of selected immunoglobulin light chain (AL) amyloidosis patients with high-dose melphalan and autologous stem cell transplantation (HDM/SCT) resulted in a high organ response rate and increased overall survival (OS), even for those patients who did not achieve a hematologic complete response (CR). | 28 Oct 2011 |
Stroke News | |
How To Reduce Stroke Threat - CDC In support of World Stroke Day on October 29, the Centers for Disease Control and Prevention call on Americans to take immediate action to reduce their risk for stroke. Every 6 seconds someone in the world dies from stroke, making it also one of the leading causes of death in the U. | 28 Oct 2011 |
Anti-Stroke Fight To Become Worldwide Health Priority - World Stroke Organization The World Stroke Organization (WSO) declares their solidarity to patients, stroke survivors and their loved ones. At today's World Stroke Day, WSO president Bo Norrving warns that, "The global burden of stroke has reached epidemic proportions and the situation will not improve until strong actions are taken. | 28 Oct 2011 |
Most Strokes Preventable, 1 In 6 Of Us Will Have One The "One in Six" motto of this year's World Stroke Day on October 29 is an apt reminder that one in six people will suffer a stroke at some point during their life and that someone dies from a stroke every 6 seconds. | 28 Oct 2011 |
Hospital Team Significantly Reduced Risk Of Further Vascular Events After 'Mini Strokes' Patients who had a transient ischaemic attack (TIA), sometimes referred to as a "mini stroke", were much less likely to experience further vascular events in the first year if their care was co-ordinated by a special hospital team. | 28 Oct 2011 |
Infection Is An Important Post-Stroke Problem After a stroke the brain tries to protect itself by blocking all inflammation. However, this also makes the patient highly susceptible to infection which can lead to death. Researchers have now discovered the mechanism behind this response and how to possibly treat it. | 28 Oct 2011 |
Transplants / Organ Donations News | |
Guilty Plea In Organ Theft Case A Legal First In what is believed to be the first legally proved case of organ trafficking, Levy Izhak Rosenbaum, 60 admitted to helping secure organs for US customers and pleaded guilt to the charges against him. | 28 Oct 2011 |
Tropical Diseases News | |
Better Understanding Of Parasite That Causes Leishmaniasis A significant step towards understanding the genetic make-up of a parasite which causes leishmaniasis - a flesh-eating disease spread by the bite of a female sand fly - has been made by a team of researchers from the University of Glasgow. | 28 Oct 2011 |
Novel Treatment Protects Mice Against Malaria; Approach May Work In Humans As Well Malaria is a major global health concern, and researchers are in need of new therapeutic approaches. To address this concern, a study published Oct. 26 in the online journal PLoS ONE reveals new information about the host cell's treatment of the parasite that causes the disease in mice, opening potential new avenues for research and treatment. | 28 Oct 2011 |
Multiple Malaria Vaccine Offers Protection To People Most At Risk A new malaria vaccine could be the first to tackle different forms of the disease and help those most vulnerable to infection, a study suggests.The new vaccine is designed to trigger production of a range of antibodies to fight the many different types of parasite causing the disease. | 28 Oct 2011 |
Vascular News | |
Anti-Coagulant Slows Down Tumor Growth And Spread According to a new study led by Dr Camille Ettelaie of the University of Hull and Dr Anthony Maraveyas, consultant oncologist from Hull's Castle Hill Hospital, anti-coagulants known collectively as Low Molecular Weight Heparin (LMWH), that are given routinely to individuals with cancer in order to treat or lower the risk of thrombosis, might restrain the growth and spread of tumors as well. | 28 Oct 2011 |
Hospital Team Significantly Reduced Risk Of Further Vascular Events After 'Mini Strokes' Patients who had a transient ischaemic attack (TIA), sometimes referred to as a "mini stroke", were much less likely to experience further vascular events in the first year if their care was co-ordinated by a special hospital team. | 28 Oct 2011 |
Veterinary News | |
Python's Bulging Heart Offers Clues For Human Heart Disease Treatment The Burmese python is a remarkable creature: it doesn't eat for a year with few ill effects, and then swallows prey like deer with a body mass that approaches 100% of its own. When it does this, its heart swells by as much as 40% over the ensuing 72 hours. | 28 Oct 2011 |
Water - Air Quality / Agriculture News | |
Boaters' Risk Of Illness On Chicago River Similar To Other Waterways Chicago area residents have wondered for years about the health risks of using the Chicago River for recreation. According to a University of Illinois at Chicago study, canoeing, kayaking, rowing, boating and fishing on the Chicago River pose the same risk of gastrointestinal illness as performing these same activities on other local waters -- a risk that turns out to be higher than that intended for swimmers at Lake Michigan beaches. | 28 Oct 2011 |
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y . |
Tidak ada komentar:
Posting Komentar